Skip to main content
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine logoLink to Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
letter
. 2020 Sep 15;16(9):1647. doi: 10.5664/jcsm.8606

COVID-19 and obstructive sleep apnea

Cristina Salles 1,, Hayssa Mascarenhas Barbosa 1
PMCID: PMC7970613  PMID: 32484776

Citation:

Salles C, Mascarenhas Barbosa H. COVID-19 and obstructive sleep apnea. J Clin Sleep Med. 2020;16(9):1647.


The authors congratulate McSharry and Malhotra on the publication “Potential influences of obstructive sleep apnea and obesity on COVID-19 severity”1 and, at the same time, pose the following question: How much sleep deprivation from obstructive sleep apnea would be an aggravating factor for the pulmonary inflammatory process in COVID-19? Sleep deprivation is reported to generate a production of inflammatory cytokines such as interleukin-6 and -17, in addition to tumor necrosis factor α, with marked neutrophilia.2,3 In the experimental study conducted by Nunes et al,4 allergic mice under sleep deprivation when using dexamethasone showed greater resistance to the anti-inflammatory effects of corticosteroids, failing to modulate interleukin-17 and tumor necrosis factor α production compared with mice without sleep deprivation. It was also observed that the allergic mice, when exposed to sleep deprivation, showed worsening of the pulmonary inflammatory process. Along these lines, sleep deprivation occurs both in asthma and obstructive sleep apnea, which can potentiate the pulmonary inflammatory process. Furthermore, Teodorescu et al5 observed that patients with asthma who used low doses of inhaled corticosteroids had an odds ratio of 2.29 to develop obstructive sleep apnea; those patients who used moderate doses increased the odds ratio to 3.67; and patients who used high doses had an odds ratio of 5.43. Therefore, obstructive sleep apnea and sleep deprivation could add to the severity of the pulmonary inflammatory process of COVID-19.

Finally, the authors congratulate McSharry and Malhotra for the study and are respectful of the considerations exposed regarding COVID-19 and obstructive sleep apnea.

DISCLOSURE STATEMENT

All authors have seen and approved the manuscript. The authors report no conflicts of interest

REFERENCES

  • 1.McSharry D, Malhotra A. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity. J Clin Sleep Med. 2020;16(9):1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–2352. [PubMed] [Google Scholar]
  • 3.Miyamoto M, Prause O, Sjöstrand M, Laan M, Lötvall J, Lindén A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol. 2003;170(9):4665–4672. 10.4049/jimmunol.170.9.4665 [DOI] [PubMed] [Google Scholar]
  • 4.Nunes JOF, Apostolico JS, Andrade DAG, et al. Sleep deprivation predisposes allergic mice to neutrophilic lung inflammation. J Allergy Clin Immunol. 2018;141(3):1018–1027. 10.1016/j.jaci.2017.06.025 [DOI] [PubMed] [Google Scholar]
  • 5.Teodorescu M, Polomis DA, Hall SV, et al. Association of obstructive sleep apnea risk with asthma control in adults. Chest. 2010;138(3):543–550. 10.1378/chest.09-3066 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine are provided here courtesy of American Academy of Sleep Medicine

RESOURCES